Currently approved treatments provide only symptomatic relief or delay symptoms of Alzheimer’s disease and Parkinson’s disease at best. The tremendous unmet medical need demands effective disease modifying therapy combined with a diagnostic biomarker for the early detection of “preclinical or asymptomatic” stages of disease, thereby enabling the halting of disease or reversal of progression.
Oral medication is the first-line treatment for scabies. Amoxicillin sildenafil pfizer ohne rezept is effective against many of the common infections. She has never had a single episode of depression or mental health concern before this.
Acephate can be purchased online, in herbal supplements, by visiting the official site of the. These maybe levitra auf rezept include the symptoms and side effects of arthritis. Ivermectin tablets online, or evermectin in europe and the u.s., ivermectin tablets on the other hand have been administered orally and subcutaneously to the adult livestock as an annual preventive or therapeutic measure to reduce parasite load in livestock by at least 80%.
Aestas Pharma Inc. is dedicated to the development of novel diagnostic imaging and therapeutic agents to enable the EARLY detection and REVERSAL of severely debilitating Alzheimer’s diseases (AD) and Parkinson’s disease (PD). In marked contrast to competitor approaches, including development stage diagnostic agents and drugs, Aestas is focused on targeting the very earliest stages of AD and PD, when clinical signs are not yet pronounced.